Fas (Human) Monoclonal Antibody (APO-1-3) from Enzo Life Sciences

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review
Microbiology-Immunology
Northwestern University
PhD Student
Fas is readily detected from Jurkat cell lysates using this antibody (1:1000) by Western blotting at 23 kDa. Treatments used show decreasing Fas abundance.

Company:

Enzo Life Sciences

Product Name:

Fas (human) monoclonal antibody (APO-1-3)

Catalog Number:

ALX-805-020

Image

Our experimental goal was to determine relative levels of Fas protein production from a common laboratory T lymphocyte cell line (Jurkat). This antibody was successfully used to detect Fas by Western blot.

Experimental Design and Results Summary

Applications

Western blotting

Sample

Jurkat whole cell lysates

Primary Incubation

Fas (APO-1-3) antibody supplied by Enzo Life Sciences (catalog #ALX-805-020). Antibody was diluted 1:1000 in blocking agent and incubated overnight at 4°C.

Blocking Agent

5% nonfat milk in Tris-buffered Saline with Tween (TBST), incubated 30 minutes at room temperature.

Secondary Incubation

Goat anti-mouse IgG-HRP supplied by Sigma-Aldrich (catalog #A4416). Antibody was diluted 1:2000 in blocking agent and incubated for 1 hour at room temperature.

Tertiary Incubation

N/A

Detection

ECL Prime Western Blotting Detection Reagent (GE Amersham, #RPN2232) used following manufacturer instructions.

Results Summary

Fas protein is readily detectable with a molecular weight around 23 kDa. No background or non-specific bands are detected and Fas signal intensity is generally strong.

Additional Notes

Jurkat cells were lysed with RIPA buffer.

Related Categories

Image Gallery

Fas is readily detected from Jurkat cell lysates using this antibody (1:1000) by Western blotting at 23 kDa. Treatments used show decreasing Fas abundance.

Summary

The Good

Strong signal intensity.

The Bad

None.

The Bottom Line

Antibody performs as expected.

Share your experience with other scientists. Write a Review! »

Join the discussion